Roche Holding AG
RHHBY
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Roche Holding AG News & Analysis
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
The 10 best global companies to invest in now
These undervalued stocks of high-quality companies are attractive investments today.
stocks
5 top US dividend shares from the best managers
These cheap dividend stocks are popular among highly rated concentrated fund managers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,071.40 | 9.10 | -0.10% |
CAC 40 | 7,802.30 | 40.98 | 0.53% |
DAX 40 | 23,647.00 | 14.05 | 0.06% |
Dow JONES (US) | 45,490.92 | 220.42 | -0.48% |
FTSE 100 | 9,270.22 | 44.83 | 0.49% |
HKSE | 26,106.01 | 94.25 | -0.36% |
NASDAQ | 21,886.06 | 6.57 | 0.03% |
Nikkei 225 | 44,372.50 | 534.83 | 1.22% |
NZX 50 Index | 13,229.15 | 47.09 | -0.35% |
S&P 500 | 6,532.04 | 19.43 | 0.30% |
S&P/ASX 200 | 8,805.00 | 8.80 | -0.10% |
SSE Composite Index | 3,875.31 | 63.09 | 1.65% |